Highlights• Continued record sales growth across all divisions...

Highlights

• Continued record sales growth across all divisions of Keytone, sales totaling more than $A24.5 million for the first 6 months of FY21, exceeding the 12-month full year FY20 result of $A22.5 million

• Rapid growth across the Company’s health halo stable of brands achieved through significantly increased ranging with major retailers across key distribution channels

• Substantial sales growth in the Australian business recording revenues of $A19.2m for the

period, well ahead of performance at the time of acquisition in mid-2019

• Significant sales growth in the New Zealand business resulting in total sales of $A5.3m in 1H

FY21 exceeding the full year 12-month result of FY20 being $5.0m

• Underlying EBITDA profitability recorded in the Australian and New Zealand operational

business units

• Strong sales and financial momentum into Q2 FY21, with cash burn reducing by 83% in the quarter to $0.7m and cash flow positive from operations in September 2020

• Successful completion of the acquisition of the assets of AusConfec, consisting of state-of-

the-art German plant and equipment for the manufacture of protein bars, acquired at a 35%

discount to the fair market value in continued use together with existing revenue streams

• Successful completion of $A12.5 million capital raise to accelerate the Company’s growth

initiatives and welcome new institutions and sophisticated investors onto the share register